Skip to content
healthcare.dev

Darifenacin

NDC 13668-202, Darifenacin, tablet, extended release, from Torrent Pharmaceuticals Limited.

Product NDC
13668-202
Status
Listed
Labeler
Torrent Pharmaceuticals Limited
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA205209
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/13668-202 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DARIFENACIN HYDROBROMIDE7.5 mg/1

Pharmacologic classes

Cholinergic Muscarinic Antagonist [EPC]; Cholinergic Muscarinic Antagonists [MoA]

Package NDCNDC-11Package
13668-202-0513668020205500 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-202-05)
13668-202-301366802023030 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-202-30)
13668-202-901366802029090 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-202-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e84f1ae3-b9a2-4a15-a299-c75373891cc1
  • NADAC price for package 13668020230

    GET /v1/drugs/nadac/13668020230
  • NADAC price for package 13668020290

    GET /v1/drugs/nadac/13668020290

Use it

Look up 13668-202 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/13668-202 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 13668-202. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.